[Federal Register Volume 65, Number 116 (Thursday, June 15, 2000)]
[Notices]
[Page 37565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-14904]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Blood Donor Recruitment Practices; Public Workshop

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
public workshop: Blood Donor Recruitment Practices. The purpose of the 
workshop is to gather information on recruiting blood donors and to 
develop recommendations on the best practices in donor recruitment in 
the United States.
    Date and Time: The public workshop will be held on July 6, 2000, 
8:30 a.m. to 5 p.m; and on July 7, 2000, 8:30 a.m. to 2 p.m.
    Locations: The July 6, 2000, workshop will be held at the National 
Institutes of Health, Lister Hill Center, 8600 Rockville Pike, Bldg. 
38A, Bethesda, MD. The July 7, 2000, workshop will be held at the same 
location, and then will move to the Natcher Conference Center, 45 
Center Dr., Bldg. 45, for breakout sessions.
    Contact: Joseph Wilczek, Center for Biologics Evaluation and 
Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike, 
Rockville, MD 20852; 301-827-6129; FAX: 301-827-2843; e-mail: 
[email protected].
    Registration: Early registration is recommended on or before June 
23, 2000. Mail or fax registration information (including name, title, 
firm name, address, telephone, and fax number) to Joseph Wilczek 
(address above). Registration at the site will be on a space-available 
basis on the day of the workshop, beginning at 7:30 a.m. There is no 
registration fee for the workshop. If you need special accommodations 
due to a disability, please contact Joseph Wilczek at least 7 days in 
advance.
    Agenda: During the first day of the workshop, speakers from the 
blood bank industry will describe successful recruitment practices. The 
topics of the presentations will include methods used in successful 
programs, donor perception, donor retention, telephone recruiting and 
scheduling, cooperative recruiting in a competitive environment, 
advertising, education, incentives, and coordinating blood collection 
with anticipated needs. During the second day, attendees will break 
into small groups to further discuss key donor recruitment issues. The 
group discussions will be developed into recommendations of the best 
practices most likely to increase blood collection to levels sufficient 
to meet future transfusion needs. At the close of the second day, the 
attendees will reconvene to share the group recommendations. The 
information gathered at the workshop may provide the basis for an FDA 
document on best practices in donor recruitment.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page. In addition, the transcript will be placed on the FDA 
Internet site at www.fda.gov/cber/minutes/workshop-min.htm.

    Dated: June 7, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-14904 Filed 6-14-00; 8:45 am]
BILLING CODE 4160-01-F